VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

NCT00117351 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped insufficient efficacy

Conditions

Carcinoma, Non-Small-Cell Lung
Adenocarcinoma, Bronchiolo-Alveolar

Interventions

DRUG: VELCADE

Sponsor

Millennium Pharmaceuticals, Inc.